top of page

TAZIME FOR INJECTION 1 g/vial

Product details

Registration number: SIN12096P

Classification: Prescription Only

Active ingredients: Ceftazidime pentahydrate with sod. carbonate1.121g/vial eqv Ceftazidime Pentahydrate

Strength: 1 g/vial

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAVENOUS; INTRAMUSCULAR

Registrant: SHOEI UNIVERSAL CORPORATION PTE LTD

ATC code: J01DD02

HSA approval date: 11 October 2002

Manufacturer(s): HANMI PHARM CO LTD

Manufacturing country/countries: KOREA, REPUBLIC OF

What are the HSA registration number and classification for TAZIME FOR INJECTION 1 g/vial?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN12096P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for TAZIME FOR INJECTION 1 g/vial?

According to the HSA dataset updated 7 August 2026:

Active ingredients: Ceftazidime pentahydrate with sod. carbonate1.121g/vial eqv Ceftazidime Pentahydrate

Strength: 1 g/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for TAZIME FOR INJECTION 1 g/vial?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAVENOUS; INTRAMUSCULAR

Source for this answer

Who is the recorded registrant for TAZIME FOR INJECTION 1 g/vial?

According to the HSA dataset updated 7 August 2026:

Registrant: SHOEI UNIVERSAL CORPORATION PTE LTD

Source for this answer

Which manufacturers and countries are listed for TAZIME FOR INJECTION 1 g/vial?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): HANMI PHARM CO LTD

Manufacturing country/countries: KOREA, REPUBLIC OF

Source for this answer

Where can I look up TAZIME FOR INJECTION 1 g/vial in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN12096P or the exact product name TAZIME FOR INJECTION 1 g/vial. The general register link does not preselect this product.

Source for this answer

What are the source dates for this TAZIME FOR INJECTION 1 g/vial record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this TAZIME FOR INJECTION 1 g/vial record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN12096P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page